{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:41:47Z","timestamp":1791312107728,"version":"4.3.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.diagmicrobio.2012.07.010","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T21:19:01Z","timestamp":1346966341000},"page":"213-223","source":"Crossref","is-referenced-by-count":148,"title":["Pharmacokinetics and pharmacodynamics of \u2018old\u2019 polymyxins: what is new?"],"prefix":"10.1016","volume":"74","author":[{"given":"Phillip J.","family":"Bergen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia B.","family":"Landersdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0005","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1128\/AAC.00284-09","article-title":"Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system","volume":"53","author":"Adams","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jac\/dkn530","article-title":"Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa","volume":"63","author":"Aoki","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0255-0857.83905","article-title":"Polymyxins: antimicrobial susceptibility concerns and therapeutic options","volume":"29","author":"Balaji","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1476-5381.1964.tb01610.x","article-title":"Sodium sulphomethyl derivatives of polymyxins","volume":"23","author":"Barnett","year":"1964","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0025","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/AAC.00079-11","article-title":"Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system","volume":"55","author":"Beceiro","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0030","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.00035-06","article-title":"Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa","volume":"50","author":"Bergen","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dkm511","article-title":"Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"61","author":"Bergen","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0040","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/AAC.00903-09","article-title":"Pharmacokinetic\/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model","volume":"54","author":"Bergen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0045","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1128\/AAC.05028-11","article-title":"Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula","volume":"55","author":"Bergen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0050","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1128\/AAC.05298-11","article-title":"Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"55","author":"Bergen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1476-5381.1967.tb01946.x","article-title":"Sodium sulphomethyl derivatives of polymyxins","volume":"29","author":"Beveridge","year":"1967","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0060","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/AAC.00881-09","article-title":"Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model","volume":"54","author":"Bulitta","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0065","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1128\/IAI.72.12.7107-7114.2004","article-title":"Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides","volume":"72","author":"Campos","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/01.CCM.0000266685.25436.03","article-title":"Efficacy of colistin\/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain","volume":"35","author":"Cirioni","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0075","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/AAC.01576-06","article-title":"Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain","volume":"51","author":"Cirioni","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1021\/jp064757+","article-title":"Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides","volume":"111","author":"Clausell","year":"2007","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0085","doi-asserted-by":"crossref","first-page":"15569","DOI":"10.1074\/jbc.M701454200","article-title":"Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides","volume":"282","author":"Clements","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0090","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thx.52.11.987","article-title":"Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis","volume":"52","author":"Conway","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1473-3099(11)70056-1","article-title":"Metallo-beta-lactamases: a last frontier for beta-lactams?","volume":"11","author":"Cornaglia","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/clpt.2011.48","article-title":"Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers","volume":"89","author":"Couet","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/chromsci\/35.12.557","article-title":"Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues","volume":"35","author":"Decolin","year":"1997","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jssc.201000680","article-title":"Validation of a novel LC-MS\/MS method for the quantitation of colistin A and B in human plasma","volume":"34","author":"Dotsikas","year":"2011","journal-title":"J Sep Sci"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0115","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/jac\/dkq134","article-title":"Evaluating the stability of colistin and colistin methanesulphonate in human plasma under different conditions of storage","volume":"65","author":"Dudhani","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/AAC.01114-09","article-title":"Elucidation of the pharmacokinetic\/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models","volume":"54","author":"Dudhani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0125","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkq226","article-title":"fAUC\/MIC is the most predictive pharmacokinetic\/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models","volume":"65","author":"Dudhani","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0021-9673(00)82091-9","article-title":"Isolation and characterization of three new polymyxins in polymyxins B and E by high-performance liquid chromatography","volume":"218","author":"Elverdam","year":"1981","journal-title":"J Chromatogr"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0135","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-5-24","article-title":"Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria","volume":"5","author":"Falagas","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10096-006-0191-2","article-title":"Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) Gram-negative bacteria","volume":"25","author":"Falagas","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2008.05.016","article-title":"Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients","volume":"32","author":"Falagas","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0160","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1128\/AAC.00242-10","article-title":"Adaptive resistance to the \u201clast hope\u201d antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS","volume":"54","author":"Fernandez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0165","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijantimicag.2008.01.011","article-title":"Colistin susceptibility testing by Etest and disk diffusion methods","volume":"31","author":"Galani","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0170","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006\u201309)","volume":"66","author":"Gales","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0175","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0180","article-title":"Predictors of changes in renal function in critically-ill patients on colistin methanesulfonate. A-1101 Slide Session 156","author":"Garonzik","year":"2011"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1179\/joc.2003.15.2.129","article-title":"Antiendotoxin activity of antimicrobial peptides and glycopeptides","volume":"15","author":"Giacometti","year":"2003","journal-title":"J Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0190","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/AAC.01367-09","article-title":"Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry","volume":"54","author":"Gobin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00216-003-2173-x","article-title":"Hyphenation of liquid chromatography to ion trap mass spectrometry to identify minor components in polypeptide antibiotics","volume":"377","author":"Govaerts","year":"2003","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0200","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/AAC.47.3.905-909.2003","article-title":"Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"47","author":"Gunderson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0140-6736(97)80051-7","article-title":"Peptide antibiotics","volume":"349","author":"Hancock","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","article-title":"Peptide antibiotics","volume":"43","author":"Hancock","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0215","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1086\/599225","article-title":"Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center","volume":"48","author":"Hartzell","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1432-1033.1996.0272n.x","article-title":"Characterization of lipopolysaccharides of polymyxin-resistant and polymyxin-sensitive Klebsiella pneumoniae O3","volume":"237","author":"Helander","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2958.1994.tb00329.x","article-title":"Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study","volume":"11","author":"Helander","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0230","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0235","series-title":"Bad bugs, no drugs","author":"Infectious Diseases Society of America","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0240","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/652237","article-title":"The 10 \u00d7 '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020","volume":"50","author":"Infectious Diseases Society of America","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0245","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.10-0463","article-title":"Steady-state pharmacokinetics and bronchoalveolar lavage concentration of colistin in critically ill patients after intravenous colistin methanesulfonate administration","volume":"138","author":"Imberti","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0250","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jpba.2008.12.016","article-title":"Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC\/MS\/MS","volume":"49","author":"Jansson","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0255","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1128\/AAC.06364-11","article-title":"The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae","volume":"56","author":"Jernigan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0260","article-title":"In vivo pharmacodynamics of colistin against Pseudomonas aeruginosa in thighs of neutropenic mice (abstract A-1)","author":"Ketthireddy","year":"2007"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0265","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2007.08.008","article-title":"Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections","volume":"60","author":"Kwa","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0275","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/cid\/cir137","article-title":"Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report","volume":"52","author":"Kwa","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0280","article-title":"Efficacy of colistin combination therapy against multidrug-resistant Gram-negative bacteria in mouse lung and thigh infection models","author":"Lee","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0285","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/AAC.45.3.781-785.2001","article-title":"In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis","volume":"45","author":"Li","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-4347(01)00326-7","article-title":"A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography","volume":"761","author":"Li","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0295","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1128\/AAC.46.10.3304-3307.2002","article-title":"Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography","volume":"46","author":"Li","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0300","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.47.5.1766-1770.2003","article-title":"Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration","volume":"47","author":"Li","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0305","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.47.4.1364-1370.2003","article-title":"Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography","volume":"47","author":"Li","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0310","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jac\/dkg468","article-title":"Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis","volume":"52","author":"Li","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkh167","article-title":"Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate","volume":"53","author":"Li","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0320","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0325","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AAC.49.11.4814-4815.2005","article-title":"Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration","volume":"49","author":"Li","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0330","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0335","first-page":"5133","article-title":"Mohnarin report 2010: surveillance of antimicrobial resistance in non-fermenting Gram-negative bacteria","volume":"21","author":"Li","year":"2011","journal-title":"Chin J Nosocomiol"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0340","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0345","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0350","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1099\/mic.0.2008\/022301-0","article-title":"Capsule polysaccharide is a bacterial decoy for antimicrobial peptides","volume":"154","author":"Llobet","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0355","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/AAC.01406-06","article-title":"Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains","volume":"51","author":"Lo-Ten-Foe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0360","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jchromb.2007.12.009","article-title":"Determination of colistin in human plasma, urine and other biological samples using LC-MS\/MS","volume":"862","author":"Ma","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0365","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/AAC.00030-09","article-title":"Renal disposition of colistin in the isolated perfused rat kidney","volume":"53","author":"Ma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0370","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1472-765X.2011.03145.x","article-title":"Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae","volume":"53","author":"Maalej","year":"2011","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0375","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/jac\/dkq185","article-title":"Removal of colistin during intermittent haemodialysis in two critically ill patients","volume":"65","author":"Marchand","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0380","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/jac\/dkq183","article-title":"Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses","volume":"65","author":"Marchand","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0385","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/AAC.00345-09","article-title":"Penetration of colistin into cerebrospinal fluid","volume":"53","author":"Markantonis","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clinthera.2008.01.015","article-title":"Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, Gram-negative bacilli infections: a prospective, open-label, uncontrolled study","volume":"30","author":"Markou","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0395","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.00834-10","article-title":"Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production","volume":"54","author":"Moffatt","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0600","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1128\/AAC.01732-10","article-title":"Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii","volume":"55","author":"Moffatt","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0405","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jb\/mvp096","article-title":"Polymyxin B identified as an inhibitor of alternative NADH dehydrogenase and malate: quinone oxidoreductase from the Gram-positive bacterium Mycobacterium smegmatis","volume":"146","author":"Mogi","year":"2009","journal-title":"J Biochem"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0410","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/AAC.06426-11","article-title":"Application of a loading dose of colistin methanesulphonate (CMS) in critically ill patients: population pharmacokinetics, protein binding and prediction of bacterial kill","volume":"56","author":"Mohamed","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0415","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/jac\/dkh485","article-title":"Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model","volume":"54","author":"Montero","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0420","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s15010-009-8342-x","article-title":"Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections","volume":"37","author":"Montero","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0425","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JB.186.2.575-579.2004","article-title":"PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A","volume":"186","author":"Moskowitz","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0430","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/AAC.38.2.374","article-title":"Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental Gram-negative infections in mice","volume":"38","author":"Ofek","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF02490480","article-title":"Development and validation of a liquid chromatography method for analysis of colistin sulphate","volume":"51","author":"Orwa","year":"2000","journal-title":"Chromatographia"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0440","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7164\/antibiotics.54.595","article-title":"Isolation and structural characterization of colistin components","volume":"54","author":"Orwa","year":"2001","journal-title":"J Antibiot"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0445","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkl512","article-title":"In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates","volume":"59","author":"Owen","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0450","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000321015","article-title":"Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii","volume":"56","author":"Ozbek","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0455","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/AAC.00367-09","article-title":"Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii","volume":"54","author":"Pachon-Ibanez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0465","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2958.2006.05512.x","article-title":"Acid pH activation of the PmrA\/PmrB two-component regulatory system of Salmonella enterica","volume":"63","author":"Perez","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0470","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0475","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jinf.2008.01.003","article-title":"Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant Gram-negative bacteria","volume":"56","author":"Pintado","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0480","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.diagmicrobio.2006.10.006","article-title":"In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii","volume":"57","author":"Plachouras","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0485","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/AAC.01361-08","article-title":"Population pharmacokinetic analysis of colistin methanesulphonate and colistin after intravenous administration in critically ill patients with Gram-negative bacterial infections","volume":"53","author":"Plachouras","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0490","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkn425","article-title":"In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae","volume":"62","author":"Poudyal","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0495","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/mdr.2011.0163","article-title":"Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City","volume":"18","author":"Quale","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0500","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.diagmicrobio.2012.04.002","article-title":"Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010","volume":"73","author":"Queenan","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.diagmicrobio.2012.07.010_bb0505","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1086\/504486","article-title":"Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species","volume":"43","author":"Rahal","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0510","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1469-0691.2010.03385.x","article-title":"New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?","volume":"16","author":"Rolain","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0515","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/INF.0b013e318207a7c1","article-title":"Pharmacokinetics of polymyxin B in an infant with multidrug-resistant Klebsiella pneumoniae bacteremia","volume":"30","author":"Salvatore","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0520","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.01271-08","article-title":"Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?","volume":"53","author":"Souli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0525","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/499819","article-title":"Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America","volume":"42","author":"Talbot","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0530","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1128\/AAC.49.9.3624-3630.2005","article-title":"Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa","volume":"49","author":"Tam","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0535","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/AAC.01571-06","article-title":"Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"51","author":"Tan","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0540","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/jac\/dkl330","article-title":"Comparison of three standardized disc susceptibility testing methods for colistin","volume":"58","author":"Tan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0545","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1179\/joc.2006.18.6.648","article-title":"Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis","volume":"18","author":"Tascini","year":"2006","journal-title":"J Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0550","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10096-009-0857-7","article-title":"Infections by pandrug-resistant Gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients","volume":"29","author":"Tsioutis","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0555","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1128\/AAC.01768-09","article-title":"In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli","volume":"54","author":"Urban","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0560","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-0711-6-8","article-title":"Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins","volume":"6","author":"van der Heijden","year":"2007","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0565","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure-activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0570","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/AAC.00103-08","article-title":"Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients","volume":"52","author":"Wallace","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0575","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/AAC.00126-11","article-title":"Pharmacokinetics\/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms","volume":"55","author":"Wang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0580","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/AAC.06486-11","article-title":"In vivo pharmacokinetics\/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection","volume":"56","author":"Wang","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0585","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0590","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1128\/AAC.35.8.1527","article-title":"Animal models in the evaluation of antimicrobial agents","volume":"35","author":"Zak","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.07.010_bb0595","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/592577","article-title":"Pharmacokinetics of intravenous polymyxin B in critically-ill patients","volume":"47","author":"Zavascki","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312003094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312003094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T15:01:43Z","timestamp":1562166103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889312003094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0732889312003094"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.07.010","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}